Total Payments
$270,089
2024 Payments
$7,402
Companies
44
Transactions
877
Medicare Patients
6,490
Medicare Billing
$833,441
Payment Breakdown by Category
Other$209,736 (77.7%)
Travel$27,312 (10.1%)
Food & Beverage$19,468 (7.2%)
Consulting$12,043 (4.5%)
Research$1,393 (0.5%)
Education$137.64 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $209,511 | 102 | 77.6% |
| Travel and Lodging | $27,312 | 46 | 10.1% |
| Food and Beverage | $19,468 | 700 | 7.2% |
| Consulting Fee | $12,043 | 6 | 4.5% |
| Unspecified | $1,393 | 15 | 0.5% |
| Honoraria | $225.00 | 1 | 0.1% |
| Education | $137.64 | 7 | 0.1% |
Payments by Type
General
$268,696
862 transactions
Research
$1,393
15 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $153,618 | 277 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $30,733 | 102 | $0 (2023) |
| GENZYME CORPORATION | $23,191 | 34 | $0 (2024) |
| Genentech USA, Inc. | $17,066 | 51 | $0 (2021) |
| Regeneron Healthcare Solutions, Inc. | $14,867 | 24 | $0 (2024) |
| Grifols USA, LLC | $13,396 | 33 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $7,408 | 20 | $0 (2019) |
| GlaxoSmithKline, LLC. | $1,979 | 110 | $0 (2023) |
| SANOFI US SERVICES INC. | $1,393 | 15 | $0 (2019) |
| Grifols Shared Services North America, Inc. | $820.00 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,402 | 10 | Boehringer Ingelheim Pharmaceuticals, Inc. ($6,966) |
| 2023 | $23,712 | 56 | Regeneron Healthcare Solutions, Inc. ($9,475) |
| 2022 | $15,140 | 44 | GENZYME CORPORATION ($5,481) |
| 2021 | $32,089 | 66 | Boehringer Ingelheim Pharmaceuticals, Inc. ($16,845) |
| 2020 | $20,067 | 118 | Boehringer Ingelheim Pharmaceuticals, Inc. ($15,695) |
| 2019 | $38,561 | 213 | Boehringer Ingelheim Pharmaceuticals, Inc. ($20,750) |
| 2018 | $44,016 | 160 | Boehringer Ingelheim Pharmaceuticals, Inc. ($20,033) |
| 2017 | $89,102 | 210 | Boehringer Ingelheim Pharmaceuticals, Inc. ($62,139) |
All Payment Transactions
877 individual payment records from CMS Open Payments — Page 1 of 36
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,350.00 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,320.00 | General |
| Category: RESPIRATORY | ||||||
| 10/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Travel and Lodging | In-kind items and services | $1,137.15 | General |
| Category: RESPIRATORY | ||||||
| 10/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $115.00 | General |
| Category: RESPIRATORY | ||||||
| 09/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $43.91 | General |
| Category: RESPIRATORY | ||||||
| 04/15/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/07/2024 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $134.33 | General |
| 01/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $149.90 | General |
| Category: Immunology | ||||||
| 01/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $61.36 | General |
| Category: Immunology | ||||||
| 01/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $76.86 | General |
| Category: Immunology | ||||||
| 12/14/2023 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $124.46 | General |
| Category: Inflammation | ||||||
| 12/14/2023 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $124.46 | General |
| Category: Respiratory | ||||||
| 12/12/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,320.00 | General |
| Category: RESPIRATORY | ||||||
| 11/30/2023 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: PAH | ||||||
| 11/29/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,350.00 | General |
| Category: RESPIRATORY | ||||||
| 11/16/2023 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,230.00 | General |
| Category: Pulmonology | ||||||
| 11/14/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $61.39 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: RESPIRATORY | ||||||
| 11/02/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $453.90 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/12/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $85.06 | General |
| Category: RESPIRATORY | ||||||
| 10/12/2023 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Respiratory | ||||||
| 10/03/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,804.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/29/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $19.47 | General |
| 09/28/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 09/28/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $6.86 | General |
| Category: RESPIRATORY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Randomized, Double-blind, Placebo-controlled, Parallel-group, 52-week Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate-to-severe Chronic Obstructi | SANOFI US SERVICES INC. | $1,393 | 15 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,269 | 1,579 | $547,215 | $148,336 |
| 2022 | 23 | 1,433 | 1,778 | $634,334 | $189,385 |
| 2021 | 30 | 1,728 | 2,318 | $825,192 | $253,820 |
| 2020 | 33 | 2,060 | 3,054 | $749,630 | $241,900 |
Total Patients
6,490
Total Services
8,729
Medicare Billing
$833,441
Procedure Codes
111
All Medicare Procedures & Services
111 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 99 | 208 | $87,520 | $34,023 | 38.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 239 | 322 | $67,620 | $30,257 | 44.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 59 | 128 | $27,648 | $11,756 | 42.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 68 | 85 | $24,225 | $10,642 | 43.9% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 20 | 20 | $34,560 | $9,467 | 27.4% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2023 | 115 | 115 | $126,500 | $6,224 | 4.9% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2023 | 13 | 13 | $21,762 | $5,996 | 27.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 42 | 42 | $17,604 | $5,667 | 32.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 79 | 83 | $12,450 | $5,168 | 41.5% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 117 | 125 | $18,750 | $5,050 | 26.9% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 99 | 105 | $12,075 | $4,107 | 34.0% |
| 31500 | Emergent insertion of breathing tube into windpipe using an endoscope | Facility | 2023 | 33 | 33 | $12,672 | $3,516 | 27.7% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 35 | 40 | $16,000 | $2,994 | 18.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 84 | 87 | $12,789 | $2,521 | 19.7% |
| 31629 | Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | Facility | 2023 | 15 | 17 | $12,750 | $2,423 | 19.0% |
| 92950 | Manual attempt to restore blood circulation and breathing | Facility | 2023 | 11 | 11 | $6,050 | $1,542 | 25.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $3,840 | $1,529 | 39.8% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2023 | 18 | 18 | $11,700 | $1,168 | 10.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 17 | 18 | $2,772 | $984.48 | 35.5% |
| 31627 | Computer-assisted image-guided navigation of lung airways using an endoscope | Facility | 2023 | 13 | 13 | $3,120 | $956.02 | 30.6% |
| 31628 | Biopsy of lobe of lung using an endoscope, 1 lobe | Facility | 2023 | 13 | 14 | $7,350 | $829.63 | 11.3% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 38 | 40 | $3,000 | $816.00 | 27.2% |
| 36620 | Insertion of artery tube for blood sampling or infusion through skin | Facility | 2023 | 18 | 18 | $4,158 | $597.82 | 14.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 12 | 12 | $300.00 | $100.80 | 33.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 130 | 270 | $113,400 | $45,404 | 40.0% |
About Dr. Mitchell Lee, MD
Dr. Mitchell Lee, MD is a Pulmonary Disease healthcare provider based in Wilmington, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053339267.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mitchell Lee, MD has received a total of $270,089 in payments from pharmaceutical and medical device companies, with $7,402 received in 2024. These payments were reported across 877 transactions from 44 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($209,511).
As a Medicare-enrolled provider, Lee has provided services to 6,490 Medicare beneficiaries, totaling 8,729 services with total Medicare billing of $833,441. Data is available for 4 years (2020–2023), covering 111 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Critical Care Medicine, Sleep Medicine
- Location Wilmington, NC
- Active Since 07/17/2006
- Last Updated 04/24/2015
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1053339267
Products in Payments
- OFEV (Drug) $57,583
- DUPIXENT (Biological) $28,729
- FASENRA (Drug) $25,577
- SPIRIVA RESPIMAT (Drug) $16,823
- Esbriet (Biological) $15,024
- Prolastin-C (Biological) $9,539
- SAMSCA (Drug) $7,518
- Prolastin-C Liquid (Biological) $4,677
- Xolair (Biological) $1,961
- DUPIXENT (Drug) $1,514
- SYMBICORT (Drug) $890.13
- ACTHAR (Biological) $823.35
- STIOLTO RESPIMAT (Drug) $693.11
- TRELEGY ELLIPTA (Drug) $610.19
- NUCALA (Biological) $579.10
- TEZSPIRE (Biological) $333.13
- CUVITRU (Biological) $325.76
- Trilogy 100 (Device) $317.26
- OPSUMIT (Drug) $299.69
- CINRYZE (Drug) $275.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Wilmington
Hector Sanchez, Md, MD
Pulmonary Disease — Payments: $116,353
Pulmonary Disease $116,353
Dr. Kevin O'neil, Md, MD
Pulmonary Disease — Payments: $1,596
Pulmonary Disease $1,596
Clifton Hunt, Md, MD
Pulmonary Disease — Payments: $1,011
Pulmonary Disease $1,011
William Credle, Md, MD
Pulmonary Disease — Payments: $678.15
Pulmonary Disease $678.15
Dr. Brian Legere, Md, MD
Pulmonary Disease — Payments: $498.97
Pulmonary Disease $498.97
Dr. Christian Lloyd, Md, MD
Pulmonary Disease — Payments: $279.25
Pulmonary Disease $279.25